44 research outputs found
Perbandingan Hasil Belajar Siswa Menggunakan Model Exclusive Antara Metode Inkuiri Dengan Verifikasi
The objective of this research was to find out the average difference of students’ learning result of EXCLUSIVE model between based on inquiry and verification. The population was 150 Grade VII students of SMPN 3 in Tegineneng in odd semester of academic year 2013/2014. There are 60 samples taken from classroom VIIA and VIIB using purposive sampling. This was research with One Group Pretest Posttest Design. Hypothesis was tested using Independent Sample T-Test. Independent sample t-test result showed that the average value of students’ learning result in classroom using EXCLUSIVE learning model based on inquiry and verification were 86.5 and 8.15 respectively. Value of tcount > ttable (3,415 > 2,042). It suggested that H0 was rejected and the conclusion that there was an average difference of students’ learning result using EXCLUSIVE learning model between inquiry based and verification based.Penelitian ini bertujuan untuk mengetahui perbedaan rata-rata hasil belajar menggunakan model EXCLUSIVE berbasis inkuiri dan verifikasi. Populasi penelitian adalah seluruh siswa kelas VII SMPN 3 Tegineneng semester ganjil tahun ajaran 2013/ 2014 sebanyak 150 siswa, sampel yang diambil kelas VIIA dan VIIB sebanyak 60 siswa. Pemilihan kelas sampel dengan metode purposive sampling. Penelitian ini menggunakan desain One-Group Pretest-Posttest Design. Pengujian hipotesis menggunakan uji Independent Sample T Test. Berdasarkan hasil uji Independent Sample T Test didapatkan nilai rata-rata hasil belajar siswa di kelas EXCLUSIVE berbasis inkuiri adalah 86,5 lebih tinggi dari kelas verifikasi yaitu 81,5. Nilai thitung > ttabel (3,415 > 2,042) maka H0 ditolak dan dapat disimpulkan bahwa ada perbedaan rata-rata hasil belajar siswa menggunakan Model pembelajaran EXCLUSIVE antara metode inkuiri dengan verifikasi
Innate immune signaling in hearts and buccal mucosa cells of patients with arrhythmogenic cardiomyopathy
Background: Nuclear factor κB (NF-κB) signaling in cardiac myocytes causes disease in a mouse model of arrhythmogenic cardiomyopathy (ACM) by mobilizing CCR2-expressing macrophages that promote myocardial injury and arrhythmias. Buccal mucosa cells exhibit pathologic features similar to those seen in cardiac myocytes in patients with ACM. Objectives: We sought to determine if persistent innate immune signaling via NF-κB occurs in cardiac myocytes in patients with ACM and if this is associated with myocardial infiltration of proinflammatory cells expressing CCR2. We also determined if buccal mucosa cells from young subjects with inherited disease alleles exhibit NF-κB signaling. Methods: We analyzed myocardium from ACM patients who died suddenly or required cardiac transplantation. We also analyzed buccal mucosa cells from young subjects with inherited disease alleles. The presence of immunoreactive signal for RelA/p65 in nuclei of cardiac myocytes and buccal cells was used as a reliable indicator of active NF-κB signaling. We also counted myocardial CCR2-expressing cells. Results: RelA/p65 signal was seen in numerous cardiac myocyte nuclei in 34 of 36 cases of ACM but not in 19 age-matched control individuals. Cells expressing CCR2 were increased in patient hearts in numbers directly correlated with the number of cardiac myocytes showing NF-κB signaling. NF-κB signaling was observed in buccal cells in young subjects with active disease. Conclusions: Patients with clinically active ACM exhibit persistent innate immune responses in cardiac myocytes and buccal mucosa cells, reflecting a local and systemic inflammatory process. Such individuals may benefit from anti-inflammatory therapy
Recommended from our members
Potential Diagnostic Role for a Combined Postmortem DNA and RNA Sequencing for Brugada Syndrome.
Recommended from our members
Innate immune signaling in hearts and buccal mucosa cells of patients with arrhythmogenic cardiomyopathy.
BACKGROUND: Nuclear factor κB (NF-κB) signaling in cardiac myocytes causes disease in a mouse model of arrhythmogenic cardiomyopathy (ACM) by mobilizing CCR2-expressing macrophages that promote myocardial injury and arrhythmias. Buccal mucosa cells exhibit pathologic features similar to those seen in cardiac myocytes in patients with ACM. OBJECTIVES: We sought to determine if persistent innate immune signaling via NF-κB occurs in cardiac myocytes in patients with ACM and if this is associated with myocardial infiltration of proinflammatory cells expressing CCR2. We also determined if buccal mucosa cells from young subjects with inherited disease alleles exhibit NF-κB signaling. METHODS: We analyzed myocardium from ACM patients who died suddenly or required cardiac transplantation. We also analyzed buccal mucosa cells from young subjects with inherited disease alleles. The presence of immunoreactive signal for RelA/p65 in nuclei of cardiac myocytes and buccal cells was used as a reliable indicator of active NF-κB signaling. We also counted myocardial CCR2-expressing cells. RESULTS: RelA/p65 signal was seen in numerous cardiac myocyte nuclei in 34 of 36 cases of ACM but not in 19 age-matched control individuals. Cells expressing CCR2 were increased in patient hearts in numbers directly correlated with the number of cardiac myocytes showing NF-κB signaling. NF-κB signaling was observed in buccal cells in young subjects with active disease. CONCLUSIONS: Patients with clinically active ACM exhibit persistent innate immune responses in cardiac myocytes and buccal mucosa cells, reflecting a local and systemic inflammatory process. Such individuals may benefit from anti-inflammatory therapy
Recommended from our members
An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.
Background Sarcoidosis is an inflammatory, granulomatous disease of unknown cause affecting multiple organs, including the heart. Untreated, unresolved granulomatous inflammation can lead to cardiac fibrosis, arrhythmias, and eventually heart failure. Here we characterize the cardiac phenotype of mice with chronic activation of mammalian target of rapamycin (mTOR) complex 1 signaling in myeloid cells known to cause spontaneous pulmonary sarcoid-like granulomas. Methods and Results The cardiac phenotype of mice with conditional deletion of the tuberous sclerosis 2 (TSC2) gene in CD11c+ cells (TSC2fl/flCD11c-Cre; termed TSC2KO) and controls (TSC2fl/fl) was determined by histological and immunological stains. Transthoracic echocardiography and invasive hemodynamic measurements were performed to assess myocardial function. TSC2KO animals were treated with either everolimus, an mTOR inhibitor, or Bay11-7082, a nuclear factor-kB inhibitor. Activation of mTOR signaling was evaluated on myocardial samples from sudden cardiac death victims with a postmortem diagnosis of cardiac sarcoidosis. Chronic activation of mTORC1 signaling in CD11c+ cells was sufficient to initiate progressive accumulation of granulomatous infiltrates in the heart, which was associated with increased fibrosis, impaired cardiac function, decreased plakoglobin expression, and abnormal connexin 43 distribution, a substrate for life-threatening arrhythmias. Mice treated with the mTOR inhibitor everolimus resolved granulomatous infiltrates, prevented fibrosis, and improved cardiac dysfunction. In line, activation of mTOR signaling in CD68+ macrophages was detected in the hearts of sudden cardiac death victims who suffered from cardiac sarcoidosis. Conclusions To our best knowledge this is the first animal model of cardiac sarcoidosis that recapitulates major pathological hallmarks of human disease. mTOR inhibition may be a therapeutic option for patients with cardiac sarcoidosis
Variation of some chemical and functional properties of Bambara groundnut (Voandzeia Subterranean L. Thouars) during sort time storage
Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.
BACKGROUND: Electrophysiological, imaging, and pathological studies have reported the presence of subtle structural abnormalities in hearts from patients with Brugada syndrome (BrS). However, data concerning disease involvement outside of the right ventricular outflow tract are limited. OBJECTIVES: This study sought to characterize the presence and distribution of ventricular myocardial fibrosis in a cohort of decedents experiencing sudden cardiac death caused by BrS. METHODS: The authors evaluated 28 whole hearts from consecutive sudden cardiac death cases attributed to BrS and 29 hearts from a comparator group comprised of noncardiac deaths (control subjects). Cardiac tissue from 6 regions across the right and left ventricle were stained with Picrosirius red for collagen and tissue composition was determined using image analysis software. Postmortem genetic testing was performed in cases with DNA retained for analysis. RESULTS: Of 28 BrS decedents (75% men; median age of death 25 years), death occurred in sleep or at rest in 24 of 28 (86%). The highest proportion of collagen was observed in the epicardial right ventricular outflow tract of the BrS group (23.7%; 95% CI: 20.8%-26.9%). Ventricular myocardium from BrS decedents demonstrated a higher proportion of collagen compared with control subjects (ratio 1.45; 95% CI: 1.22-1.71; P < 0.001), with no significant interactions with respect to sampling location or tissue layer. There was insufficient evidence to support differences in collagen proportion in SCN5A-positive cases (n = 5) when compared with control subjects (ratio 1.23; 95% CI: 0.75-1.43; P = 0.27). CONCLUSIONS: Brugada syndrome is associated with increased collagen content throughout right and left ventricular myocardium, irrespective of sampling location or myocardial layer
Development and design of objective structured clinical examinations (OSCE) in undergraduate pharmacy education in a new School of Pharmacy in England.
Original article can be found at : http://www.sciencedirect.com/ Copyright ElsevierUK pharmacy practice is driven by competency-based healthcare practice and the expanding clinical roles of pharmacy practitioners. Setting up a new School of Pharmacy offers the opportunity to design a program appropriate for the needs of the future pharmacy workforce. Objective structured clinical examinations (OSCEs) offer the opportunity to assess students in their handling of real life pharmacy practice scenarios, and allow students to develop and hone communication and problem-solving skills. This paper describes the development and design of OSCEs in the undergraduate pharmacy degree at the University of Hertfordshire. The framework of formative and summative OSCEs across the 4-year degree program is discussed, as are the logistics of setting up and running OSCEs, tutor training, feedback, and reflections on the experience to date and future direction. The OSCEs have been implemented successfully into the undergraduate pharmacy curriculum with positive feedback from staff and students.Peer reviewe
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
Background: Inflammation is a prominent feature of arrhythmogenic cardiomyopathy (ACM), but whether it contributes to the disease phenotype is not known. Methods: To define the role of inflammation in the pathogenesis of ACM, we characterized NFκB signaling in ACM models in vitro and in vivo, and in cardiac myocytes from patient induced pluripotent stem cells (hiPSCs). Results: Activation of NFκB signaling, indicated by increased expression and nuclear accumulation of phospho-RelA/p65, occurred in both an in vitro model of ACM (expression of JUP2157del2 in neonatal rat ventricular myocytes), and in a robust murine model of ACM (homozygous knock-in of mutant desmoglein-2; Dsg2mut/mut) that recapitulates the cardiac manifestations seen in ACM patients. Bay 11-7082, a small molecule inhibitor of NFκB signaling, prevented development of ACM disease features in vitro (abnormal redistribution of intercalated disk proteins, myocyte apoptosis, release of inflammatory cytokines) and in vivo (myocardial necrosis and fibrosis, LV contractile dysfunction, ECG abnormalities). Hearts of Dsg2mut/mut mice expressed markedly increased levels of inflammatory cytokines and chemotactic molecules which were attenuated by Bay 11-7082. Salutary effects of Bay 11-7082 correlated with the extent to which production of selected cytokines had been blocked. NFκB signaling was also activated in cardiac myocytes derived from a patient with ACM. These cells produced and secreted abundant inflammatory cytokines under basal conditions, and this was also greatly reduced by Bay 11-7082. Conclusions: Inflammatory signaling is activated in ACM and it drives key features of the disease. Targeting inflammatory pathways may be an effective new mechanism-based therapy for ACM